Interventional Cardiologists archivos | Page 13 of 43

Acute coronary syndromes

Reduced risk of acute, late and very late thrombosis with new generations of DES versus BMS in the acute myocardial context

Original title: Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from...

solaci - 11 July, 2014

Learn More

Femoropopliteal

Superficial Femoral Artery In-Stent Restenosis with Drug Eluting Balloon: 2 Year Follow Up.

Original title: Drug-Eluting Balloons for the Treatment of the Superficial Femoral Artery In-Stent Restenosis. 2-Year Follow-Up. Reference: Vittorio Virga et...

solaci - 8 July, 2014

Learn More

Chronic Ischemic cardiopathy

SYNTAX study final monitoring at 5-years

Original title: Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up...

solaci - 4 July, 2014

Learn More

Congenital cardiopathy

Stent therapy for coarctation of aorta

Original title: Acute outcome of stent therapy for coarctation of the aorta: results of the coarctation of the...

solaci - 2 July, 2014

Learn More

Acute coronary syndromes

Percutaneous Closure of Postinfarction Ventricular Septal Defect, an early alternative to surgery.

Original title: Percutaneous Closure of Postinfarction Ventricular Septal Defect: In-Hospital Outcomes and Long-Term Follow-Up of UK Experience. Reference: Circulation. 2014...

solaci - 1 July, 2014

Learn More

Acute coronary syndromes

Best ejection fraction using Metoprolol as pretreatment in acute myocardial infarction

Original title: Long-Term Benefict of Early Pre-Reperfusion Metoprolol Administraction in Patients With Acute Myocardial Infaction. From the METOCARD-CNIC...

solaci - 25 June, 2014

Learn More

Antithrombotic Anticoagulants

3 to 6 months of dual antiplatelet after DES reduced bleeding and did not raise mortality or infarction.

Original title: Meta-analysis of randomized clinical trials comparing short term -vs- long term dual antiplatelet therapy following drug...

solaci - 24 June, 2014

Learn More

Coronary disease

Cohort with left main coronary injury of SYNTAX. Final monitoring at 5 years.

Original title: Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary...

solaci - 19 June, 2014

Learn More

Interventional Cardiologists

Reduced risk of acute, late and very late thrombosis with new generations of DES versus BMS in the acute myocardial context

Superficial Femoral Artery In-Stent Restenosis with Drug Eluting Balloon: 2 Year Follow Up.

SYNTAX study final monitoring at 5-years

Stent therapy for coarctation of aorta

Percutaneous Closure of Postinfarction Ventricular Septal Defect, an early alternative to surgery.

Best ejection fraction using Metoprolol as pretreatment in acute myocardial infarction

3 to 6 months of dual antiplatelet after DES reduced bleeding and did not raise mortality or infarction.

Cohort with left main coronary injury of SYNTAX. Final monitoring at 5 years.

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Institutional News

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Check out the best images of the Arequipa 2024 Sessions

Access